TO EVALUATE THE NEUROPROTECTIVE ACTIVITY OF STRAWBERRY AND BLUEBERRY EXTRACT IN MPTP-INDUCED PARKINSONISM IN MICE
DOI:
https://doi.org/10.22159/ijcpr.2026v18i1.7089Keywords:
Parkinson’s disease, MPTP, Neuroprotection, Strawberry extract, Blueberry extract, Behavioural assessment, Oxidative stress, Syndopa (Levodopa+Carbidopa)Abstract
Objective: This study aimed to evaluate the neuroprotective effects of ethanolic extracts of strawberry and blueberry in an MPTP-induced mouse model of Parkinsonism.
Methods: Swissmice (30–35 g) were divided into five groups: control, MPTP-treated, Syndopa (Levodopa+Carbidopa)-treated, low-dose extract-treated, and high-dose extract-treated groups. Parkinsonism was induced using MPTP (20 mg/kg) for seven consecutive days. Mice were then administered either Syndopa (10 mg/kg) or strawberry and blueberry extracts at low (100 mg/kg) or high (200 mg/kg) doses for Seven days. Behavioural assessments, including the Rotarod test, Grip test/Hang test, Open-field test, Actophotometer test, Forced Swim test, Elevated plus maze test, and Catalepsy/Wooden bar test, were conducted to evaluate motor function, anxiety-like behaviour, and catalepsy.
Results: MPTP administration led to significant motor impairments, increased catalepsy, and reduced locomotor activity. Treatment with strawberry and blueberry extracts significantly improved motor coordination, reduced cataleptic symptoms, and enhanced locomotor activity in a dose-dependent manner. The observed neuroprotective effects were comparable to those of Syndopa (Levodopa+Carbidopa)-treated, suggesting that bioactive compounds in these fruits may mitigate neurodegeneration.
Conclusion: The results support the potential of strawberry and blueberry extracts as natural therapeutic agents in Parkinson’s disease. Their antioxidant and neuroprotective properties warrant further investigation into the underlying mechanisms and potential clinical applications in PD management.
Downloads
References
1. Hyder F, Rothman DL, Bennett MR. Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels. Proc Natl Acad Sci USA. 2013;110(9):3549-54. doi: 10.1073/pnas.1214912110, PMID 23319606.
2. Wichmann T, De Long MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol. 1996;6(6):751-8. doi: 10.1016/S0959-4388(96)80024-9, PMID 9000030.
3. Benabid AL. Deep brain stimulation for Parkinson’s disease. Curr Opin Neurobiol. 2003;13(6):696-706. doi: 10.1016/j.conb.2003.11.001.
4. Schapira AH. Science, medicine and the future: Parkinson’s disease. BMJ. 1999;318(7179):311-4. doi: 10.1136/bmj.318.7179.311, PMID 9924061.
5. Nombela C, Rowe JB, Winder Rhodes SE, Hampshire A, Owen AM, Breen DP. Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain. 2014;137(10):2743-58. doi: 10.1093/brain/awu201, PMID 25080285.
6. Ball N, Teo WP, Chandra S, Chapman J. Parkinson’s disease and the environment. Front Neurol. 2019 Mar;10:218. doi: 10.3389/fneur.2019.00218, PMID 30941085.
7. Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci. 2007;120(10):1707-16. doi: 10.1242/jcs.03443, PMID 17502481.
8. Heemels MT. Neurodegenerative diseases. Nature. 2016;539(7628):179. doi: 10.1038/539179a, PMID 27830810.
9. Miller K, Feucht W, Schmid M. Bioactive compounds of strawberry and blueberry and their potential health effects based on human intervention studies: a brief overview. Nutrients. 2019;11(7):1510. doi: 10.3390/nu11071510, PMID 31269727.
10. Shi M, Loftus H, McAinch AJ, Su XQ. Blueberry as a source of bioactive compounds for the treatment of obesity type 2 diabetes and chronic inflammation. J Funct Foods. 2017;30:16-29. doi: 10.1016/j.jff.2016.12.036.
11. Kim HG, Ju MS, Shim JS, Kim MC, Lee SH, Huh Y. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson’s disease models. Br J Nutr. 2010;104(1):8-16. doi: 10.1017/S0007114510000218, PMID 20187987.
12. Nellore J, Amarnath K. Development and in vitro evaluation of strawberry fruit extract-loaded biodegradable nanoparticles in therapy for neurodegenerative disorders. In: International Conference on Nanoscience Engineering and Technology (ICONSET 2011). New York: IEEE; 2011. p. 396-400. doi: 10.1109/ICONSET.2011.6167988.
13. Spohr L, Luduvico KP, Soares MS, Bona NP, Oliveira PS, De Mello JE. Blueberry extract as a potential pharmacological tool for preventing depressive-like behavior and neurochemical dysfunctions in mice exposed to lipopolysaccharide. Nutr Neurosci. 2022;25(4):857-70. doi: 10.1080/1028415X.2020.1819104, PMID 32954970.
14. Kumar SV, Kumar SP, Rupesh D, Nitin K. Journal of chemical and pharmaceutical research preparations. J Chem Pharm Res. 2011;3(1):675-84.
15. Manna S, Bhattacharyya D, Mandal TK, Dey S. Neuropharmacological effects of deltamethrin in rats. J Vet Sci. 2006;7(2):133-6. doi: 10.4142/jvs.2006.7.2.133, PMID 16645337.
16. Deacon RM. Measuring motor coordination in mice. J Vis Exp. 2013;(75):e2609. doi: 10.3791/2609, PMID 23748408.
17. Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson’s disease. Behav Brain Res. 2015;281:215-21. doi: 10.1016/j.bbr.2014.12.035, PMID 25541039.
18. Wang XL, Xing GH, Hong B, Li XM, Zou Y, Zhang XJ. Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson’s disease: involvement of ERK1/2-Nrf2 signaling pathway. Life Sci. 2014;114(2):77-85. doi: 10.1016/j.lfs.2014.08.004, PMID 25132361.
19. Khatri DK, Juvekar AR. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson’s disease. Pharmacol Biochem Behav. 2016;150-151:39-47. doi: 10.1016/j.pbb.2016.09.002, PMID 27619637.
20. Ruan S, Xie J, Wang L, Guo L, Li Y, Fan W. Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson’s disease. Front Pharmacol. 2023 Feb;14:1088957. doi: 10.3389/fphar.2023.1088957, PMID 36817162.
21. Harish G Bagewadi, Rajeshwari, Patil Banderao V, Syed Hasan Zahid. Rotarod test and catalepsy bar test: behavioral testing and neuromodulation of Aloe vera in MPTP-induced Parkinson’s disease animal model. Int J Basic Clin Pharmacol. 2018;7(3):494. doi: 10.18203/2319-2003.ijbcp20180663.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.